Close Menu

NEW YORK (360Dx) – Attis Industries announced Monday that it has received a Medicare license for its new toxicology laboratory based in Tulsa, Oklahoma.

The lab, which received its CLIA license in August, will serve as a federal lab dedicated to running samples reimbursed by Medicare and state Medicaid programs only. The company plans to begin accepting samples and billing under its Medicare number immediately. The lab's new CMS license provides Medicare coverage for all states.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.


This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.